Nuclear medicine studies used for diagnosis of<unk>  include fluorodeoxyglucose-18F positron emission tomography (18F- FDG PET) scan and metaiodobenzylguanidine (123I-MIBG) scintigraphy. 18F-FDG PET scan may distinguish stage 1 and 2<unk>  from other differential diagnoses. 123I- MIBG scintigraphy distinguishes stage 3 and 4<unk>  other differential diagnoses.
Neuroblastoma other imaging findings
Esthesioneuroblastoma other imaging findings
Neuroblastoma other diagnostic studies
Myxoma other imaging findings
Germinoma other imaging findings
Atypical teratoid rhabdoid tumor other imaging findings
Esthesioneuroblastoma other diagnostic studies
Oligoastrocytoma other imaging findings